Affordable Access

Slowing progression along the renal disease continuum.

Authors
  • Kopyt, Nelson P
Type
Published Article
Journal
The Journal of the American Osteopathic Association
Publication Date
Apr 01, 2005
Volume
105
Issue
4
Pages
207–215
Identifiers
PMID: 15928338
Source
Medline
License
Unknown

Abstract

Patients in whom nephropathy develops as a result of hypertension or diabetes mellitus are more likely to die of cardiovascular disease (CVD) than of kidney disease. An early sign of impending nephropathy is microalbuminuria, defined as urinary excretion of albumin at a rate of 28.8 mg/24 h to 288 mg/24 h. Microalbuminuria is a marker of endothelial dysfunction, vascular injury, and renal disease and CVD, and it is associated with increased risk for myocardial infarction. Oxidative stress and endothelial dysfunction are unifying factors mediated by the renin-angiotensin system in renal disease and CVD. Clinical trials show reduced cardiovascular risk and a reversal of microalbuminuria with the use of agents that affect the renin-angiotensin system: angiotensin-receptor blockers in patients with type 2 diabetes mellitus and nephropathy, or angiotensin-converting enzyme inhibitors in patients with type 1 diabetes mellitus.

Report this publication

Statistics

Seen <100 times